Forget the cash ISA. I’d buy these 2 investment trusts instead

Harvey Jones picks out two successful investment trusts with history on their side.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investment trusts are the unsung heroes of the investment world. They have been quietly going about their business for decades and in some cases more than a century.

Happy 130th birthday!

The Merchants Trust (LSE: MRCH) celebrates its 130th birthday this year, having been launched in 1889, the year the Eiffel Tower was opened and Van Gogh painted his Starry Night. It may not be as famous, but it has also stood the test of time.

The £507m trust aims to deliver market-beating income and long-term capital growth from a portfolio of higher yielding large UK companies. It is targeted at investors who want a spread of mainstream UK stocks, judging by its top 10 holdings.

Pick and choose

These are all FTSE 100 dividend income stalwarts such as Royal Dutch Shell, GlaxoSmithKline, HSBC Holdings, Imperial Brands, BP, SSE… need I go on? Many of you will prefer to buy stocks like these directly yourself, but if you want to hand over the reins, this could be for you.

As portfolio manager Simon Gergel points out, this trust has survived two world wars, the great depression, the global financial crisis and the 1970s inflationary shock. “Somehow today’s uncertainties over Brexit and Donald Trump’s trade spat with China don’t seem so threatening,” he adds.

Historic performance

UK equities have underperformed global stock markets lately but the trust has risen 38.8% in the last three years, according to, against 28.4% on its benchmark UK equity income index. However, it trails over five years, growing 22% against 26.9% for its benchmark.

Like many investment trusts, management charges are low, with a total ongoing charges figure (OCF) of just 0.59%. I usually prefer trusts trading at a slightly larger discount than Merchants, currently just -0.2%, but this is one in demand. It also has an impressive yield of 5.5%. Not many funds offer that.

So should you buy this instead of, say, a tracker such as HSBC FTSE All Share Index, which has a rock bottom OCF of just 0.06%? This fund’s three-year performance is slightly weaker at 36.9%, but it has beaten Merchants over five years growing 31.5%. The yield is currently lower, though, at 3.99%. Income seekers may decide Merchants just has the edge. These two investment trusts might also tempt you.

Think small

BMO Global Smaller Companies (LSE: BGSC) is also celebrating its 130th birthday and has grown strongly after the board switched focus to smaller companies in 1975. It is now worth more than £800m.

Now, I personally believe that trackers are the best way to tap into well-researched large-caps while active management is better suited to riskier and less researched smaller firms. So how does BMO do? Pretty well, frankly. It is up 48.8% over three years and 64.3% over five, and although it trails its benchmark IT Global index, this may reflect the strong performance of huge US technology stocks that this fund does not touch.

Size isn’t everything

This trust gives you access to smaller global stocks you would never unearth yourself, plus exposure to specialist funds such as Aberdeen Japanese Smaller Companies, spreading risk. It has global exposure but with plenty of US focus (39%) and UK (25%). Check if this balances your portfolio. Charges on smaller-cap funds are usually slightly higher but an OCF of 0.83% is respectable, as is performance.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

harveyj has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended HSBC Holdings and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Despite rising 152% in a year, is Rolls-Royce’s share price still a bargain?

While Rolls-Royce’s share price has shot up recently, it still looks very undervalued against its peers, and the business looks…

Read more »

Investing Articles

Could Nvidia stock be a bargain in plain sight?

Nvidia stock has surged 252% over the past 12 months, but that doesn't mean it's expensive. In fact, it may…

Read more »

Investing Articles

Here’s why I think the Vodafone share price should be 110% higher

Reflecting on speculation, our writer believes there’s a case to be made for the Vodafone share price being more than…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this dividend star also the best bargain in the FTSE 100?

This FTSE 100 stock pays a whopping 8%+ yield, looks very undervalued against its peers, and is set for stellar…

Read more »

Investing Articles

2 FTSE 100 stocks. One sublime, the other ridiculous

Our writer doesn’t understand the appeal of Ocado. But looking at the grocer’s latest results makes him see the attraction…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 18% in a year, what’s next for the Greatland Gold (GGP) share price?

The Greatland Gold share price has disappointed over the past 12 months. Our writer asks whether the company’s latest update…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With 30% annual returns for a decade, I’m buying this for my Stocks & Shares ISA

Oliver Rodzianko has been looking for a new investment for his Stocks and Shares ISA. Here's one he's decided is…

Read more »

Investing Articles

These were the FTSE 100’s dogs and stars in February

The FTSE 100 limped along last month, but some Footsie shares soared while others slumped. Here are February's winners and…

Read more »